Agilent Technologies stock is trading -12.99% below its average target price of $140.58 after dropping -2.7% during today's afternoon session. Analysts are giving the large-cap Biotechnology company an average rating of buy and target prices ranging from $115.0 to $163.0 per share.
Agilent Technologies's short interest — meaning the percentage of the share float that is being shorted — is lower than average at 1.7%. The stock's short ratio is 2.34. The company's insiders own 0.3% of its outstanding shares, which indicates a strong alignment between management and shareholder interests.
Another number to watch is the company's rate of institutional share ownership, which now stands at 91.5%. In conclusion, we believe there is mixed market sentiment regarding Agilent Technologies.
Institutions Invested in Agilent Technologies
Date Reported | Holder | Percentage | Shares | Value |
---|---|---|---|---|
2023-06-30 | Blackrock Inc. | 11% | 31,853,176 | $3,896,280,478 |
2023-06-30 | Vanguard Group Inc | 9% | 25,199,676 | $3,082,424,360 |
2023-06-30 | State Street Corporation | 4% | 13,214,595 | $1,616,409,256 |
2023-06-30 | Massachusetts Financial Services Co. | 4% | 11,037,240 | $1,350,075,193 |
2023-06-30 | T. Rowe Price Investment Management, Inc. | 3% | 9,967,550 | $1,219,230,712 |
2023-06-30 | Wellington Management Group, LLP | 3% | 8,736,392 | $1,068,635,466 |
2023-06-30 | Price (T.Rowe) Associates Inc | 3% | 8,053,975 | $985,162,219 |
2023-06-30 | Pictet Asset Management SA | 2% | 6,644,015 | $812,695,912 |
2023-06-30 | Geode Capital Management, LLC | 2% | 6,378,218 | $780,183,623 |
2023-06-30 | Morgan Stanley | 2% | 4,793,914 | $586,391,559 |